A drug that selectively clears dysfunctional immune cells reversed liver damage in mice despite their continued consumption of an unhealthy diet. It’s a biological contradiction: the external trigger for the disease remained, but the internal damage vanished.
UCLA researchers have uncovered a rogue population of immune cells that accumulate in aging tissues and the livers of patients with fatty liver disease. These cells, termed “zombie macrophages,” don’t divide or die. Instead, they linger in the tissue and secrete a toxic stream of inflammatory signals that damage surrounding healthy cells.
“Senescent cells are fairly rare, but think of them like a broken-down car on the 405,” said Anthony Covarrubias, senior author of the study. “Just one stalled car can back up traffic for miles. Now imagine five or ten of them slowly accumulating.”
Why a specific protein marker matters
Identifying these cells has been difficult because healthy macrophages share several molecular traits with senescent ones. The UCLA team solved this by identifying a distinct molecular signature: the combination of two proteins, p21 and TREM2.
The difference in cell populations is stark across age groups. In young mice, only about 5% of liver macrophages were senescent. In older mice, that figure jumped to between 60% and 80%, mirroring the rise in chronic liver inflammation associated with aging.
Excess cholesterol triggers cellular senescence
Aging isn’t the only catalyst. The researchers found that high levels of LDL cholesterol can force healthy macrophages into a permanently inflamed, senescent state.
Ivan Salladay-Perez, first author of the study, noted that although macrophages can normally handle cholesterol metabolism, a chronic state becomes pathological. Overnutrition and excessive blood cholesterol appear to be primary drivers of this zombie cell population.
In mice, clearing these cells reversed damage
Treating mice with a senolytic drug that targeted these specific macrophages reduced liver inflammation and steatosis. The reversal occurred regardless of the animals’ diet, suggesting a therapeutic path that doesn’t rely solely on lifestyle changes.
This discovery shifts the stakeholder framing of metabolic liver disease. If cellular clearance can bypass dietary restrictions, the “win” moves from patient discipline to pharmaceutical intervention. It reveals that high-cholesterol diets may accelerate biological aging at a cellular level, effectively “aging” the liver faster than the rest of the body.
The findings are particularly relevant given that fatty liver disease affects an estimated 30-40% of Los Angeles residents. While human trials aren’t mentioned, the results in mice suggest that targeting macrophage senescence could turn into a viable strategy for treating metabolic dysfunction-associated steatotic liver disease.
What are zombie cells?
Zombie cells, or senescent cells, are cells that have stopped dividing due to stress but refuse to die. They remain active in the body and release inflammatory signals that damage nearby healthy tissues.
How do scientists identify these specific immune cells?
Researchers leverage a molecular signature consisting of two proteins, p21 and TREM2, to distinguish truly senescent macrophages from healthy ones.
